Home » Topics » BioWorld Science

BioWorld Science
RSS

MMP inhibitors claimed by AstraZeneca for arthritis, atherosclerosis and COPD

Oct. 22, 2001

Amide 5-HT antagonists and their uses described in recent patent

Oct. 22, 2001

Yamanouchi presents new inhibitors of CRACC and IL-2 production

Oct. 22, 2001

Basidiomycete found to produce new cytokine inhibitors CJ-14877 and CJ-14897

Oct. 22, 2001

New antiepileptic drug SPD-421 advances through development pipeline

Oct. 22, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Interim findings presented for phase I clinical trials of J591 for prostate cancer

Oct. 22, 2001

Adenovirus-mediated VEGF-A gene therapy enhances bone formation in animal model

Oct. 22, 2001

Ara-CBP: effects on human osteoblasts and breast cancer cells described at ASBMR meeting

Oct. 22, 2001

CPMP recommends approval of Gilead's Viread for HIV infection

Oct. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...